Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice

Citation
Dp. Rose et Jm. Connolly, Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice, INT J ONCOL, 15(5), 1999, pp. 1011-1015
Citations number
38
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF ONCOLOGY
ISSN journal
10196439 → ACNP
Volume
15
Issue
5
Year of publication
1999
Pages
1011 - 1015
Database
ISI
SICI code
1019-6439(199911)15:5<1011:AODAAI>2.0.ZU;2-H
Abstract
The addition of the omega-3 fatty acid (n-3 FA) docosahexaenoic acid (DHA), 4%, to a 20% (wt/wt) fat diet containing 4% linoleic acid (LA, n-6 FA) par tially suppressed the growth of the MDA-MB-231 human breast cancer cell lin e as solid tumors in athymic nude mice. This reduced tumor growth was assoc iated with significant inhibition of cell proliferation, as indicated by di minished Ki-67 nuclear proliferation marker expression, and an increase in TUNEL positive (apoptotic) cells (both p<0.001). The microvessel counts wer e also reduced in tumors from the DHA-supplemented dietary group of mice (p <0.001), and this suppression of angiogenesis was positively correlated wit h loss of Ki-67 expression. Tumor vascular endothelial cell growth factor ( VEGF) concentrations were not reduced in the DHA-fed mice. It is postulated that the antiangiogenicity of DHA in this breast cancer model is related t o our demonstrated inhibition of LA-derived prostaglandin E2, 12-hydroxy-ei cosatetraenoic acid (12-HETE) and 15-HETE synthesis, reducing the paracrine stimulation by these known angiogenic eicosanoids on microvessel endotheli al cells.